Relationship Between Adrenergic Activity and Cardiac Actions of Quinidine
- 1 October 1962
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 11 (4) , 758-764
- https://doi.org/10.1161/01.res.11.4.758
Abstract
Unanesthetized dogs with complete heart block were used to explore the relationship between adrenergic activity and quinidine action on the heart. After vagolysis, quinidine still increased both the atrial and ventricular rates. Following reduction in adrenergic activity by reserpine, hexamethonium, or surgical sympathectomy, the atrial and ventricular pacemakers were depressed. After sympathetic activity had been reduced by a combination of hexamethonium and reserpine, quinidine caused profound pacemaker depression and sometimes ventricular asystole. Quinidine produced coupling and occasionally runs of ventricular tachycardia independent of the level of sympathetic activity. There was no significant prolongation of the QRS time by quinidine in doses of 5 and 10 mg./Kg. Both the development of ectopic pacemakers and the depression of pacemaker activity of quinidine were dose dependent.This publication has 9 references indexed in Scilit:
- Pharmacological Evidence for the Importance of Catecholamines in Cardiac RhythmicityCirculation Research, 1961
- Effect of Reserpine on Ventricular EscapeScience, 1960
- A METHOD FOR THE EVALUATION OF DEPRESSANTS OF SUBATRIAL RHYTHMIC FUNCTION IN THE HEART OF THE INTACT ANIMAL1960
- THE RELEASE OF NOREPINEPHRINE FROM THE MAMMALIAN HEART BY RESERPINE1958
- THE INITIATION AND PHARMACOLOGIC REACTIVITY OF A VENTRICULAR PACEMAKER IN THE INTACT ANIMAL1956
- Adams-Stokes syndrome: The treatment of ventricular asystole, ventricular tachycardia and ventricular fibrillation associated with complete heart blockThe American Journal of Medicine, 1955
- THE EPINEPHRINE AND HYDROCARBON-EPINEPHRINE DISTURBANCE IN THE CAT1955
- DEPRESSION OF THE HEART BY QUINIDINE AND ITS TREATMENTHeart, 1954
- The use of quinidine in ambulatory patients for the prevention of paroxysms of auricular flutter and fibrillation; with especial reference to dosage and the effects on intraventricular conductionAmerican Heart Journal, 1933